CompanyGraphAt a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionOperating margin is -97.5%, lower than 95% of its Medical Devices peers (median 7.3%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
733.05BKRW528.76M · vs all stocks (USD)
Revenue (TTM)
52.82BKRW38.10M · vs all stocks (USD)
Profit Margin
-50.25%vs Medical Devices peers
52-Week Change
-46.00%vs all stocks
Market Capitalization
733.05BKRW528.76M · vs all stocks (USD)
Enterprise Value
695.47BKRW501.66M · vs all stocks (USD)
Forward P/E
28.39xvs Medical Devices peers
Price to Sales (TTM)
13.95xvs Medical Devices peers
Enterprise to Revenue
13.17xvs Medical Devices peers
Enterprise to EBITDA
-25.41xvs Medical Devices peers
Profit Margin
-50.25%vs Medical Devices peers
Operating Margin
-97.46%vs Medical Devices peers
Return on Assets (TTM)
-14.81%vs Medical Devices peers
Return on Equity (TTM)
-24.04%vs Medical Devices peers
Revenue (TTM)
52.82BKRW38.10M · vs all stocks (USD)
Revenue per Share (TTM)
2.23KKRWUpdated Sep 21, 2026Quarterly Revenue Growth
9.60%vs Medical Devices peers
Gross Profit (TTM)
26.47BKRW19.09M · vs all stocks (USD)
EBITDA (TTM)
-27.37BKRW-19.74M · vs all stocks (USD)
Net Income (TTM)
-26.54BKRW-19.14M · vs all stocks (USD)
Operating Cash Flow (TTM)
-45.35BKRW-32.71M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-66.97BKRW-48.31M · vs all stocks (USD)
Shares Outstanding
24.68MSharesUpdated Sep 21, 2026Float Shares
13.55MSharesUpdated Sep 21, 2026% Held by Insiders
44.26%vs all stocks
% Held by Institutions
4.81%vs all stocks
Total Cash (MRQ)
64.56BKRW46.56M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.58KKRWUpdated Sep 21, 2026Total Debt (MRQ)
13.65BKRW9.84M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0832xvs Medical Devices peers
Current Ratio (MRQ)
7.81xvs Medical Devices peers
52-Week Low
27.10KKRWUpdated Sep 21, 202652-Week High
95.90KKRWUpdated Sep 21, 202652-Week Change
-46.00%vs all stocks
50-Day MA
37.07KKRWUpdated Sep 21, 2026200-Day MA
56.26KKRWUpdated Sep 21, 2026Avg 10-Day Volume
217.16KSharesUpdated Sep 21, 2026Avg 30-Day Volume
197.21KSharesUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -97.5%, lower than 95% of its Medical Devices peers (median 7.3%)Significant
Operating margin: -0.97Industry median: 0.07Industry P5: -0.73Peers compared: 102
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Senseonics Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Eupraxia Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cerus Corporation
Tier 1ProductionApproval-Gated PipelineRule
Prime Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Lifestrong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Easydiagnosis Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Clarity Pharmaceuticals Ltd
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Pulike Biological Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kingchem Liaoning Life Science Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CHA Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Md Entertainment Tbk
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated